1. Home
  2. AIRI vs GDTC Comparison

AIRI vs GDTC Comparison

Compare AIRI & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Air Industries Group

AIRI

Air Industries Group

HOLD

Current Price

$3.01

Market Cap

14.9M

Sector

Industrials

ML Signal

HOLD

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$1.01

Market Cap

12.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRI
GDTC
Founded
1979
2018
Country
United States
Singapore
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.9M
12.4M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
AIRI
GDTC
Price
$3.01
$1.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
45.6K
17.9K
Earning Date
05-14-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
24.39
N/A
EPS
N/A
N/A
Revenue
$47,921,000.00
N/A
Revenue This Year
$6.43
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.55
$0.68
52 Week High
$4.17
$3.68

Technical Indicators

Market Signals
Indicator
AIRI
GDTC
Relative Strength Index (RSI) 48.58 42.73
Support Level $3.01 $0.94
Resistance Level $3.13 $1.09
Average True Range (ATR) 0.06 0.08
MACD 0.00 -0.02
Stochastic Oscillator 14.29 7.44

Price Performance

Historical Comparison
AIRI
GDTC

About AIRI Air Industries Group

Air Industries Group is an aerospace and defense company. Its manufacturers of precision components and assemblies for large aerospace and defense prime contractors. The company products include landing gears, flight controls, engine mounts and components for aircraft jet engines, ground turbines and other complex machines. The ultimate end-user of products is the U.S. Government, international governments, and commercial global airlines.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: